Description

Join McDermott for our 13th Annual Life Sciences Dealmaking Symposium on November 6 at Boston’s stunning Omni Seaport. It’s the must-attend event for the life sciences industry: an unrivaled combination of education, networking and investment opportunities.

There’s nothing else like it. Here’s why:

Connect: Meet and network with the industry’s top decision makers, including investors, founders, private equity firms, in-house counsel, C-suite executives and other influential figures.

Learn: Hear presentations from industry leaders about what’s next. Confirmed presenters include John Maraganore, PhD, founding CEO of Alnylam Pharmaceuticals, Inc, and CEO and principal of JMM Innovations, LLC.

Plan: Symposium programming is geared to deliver actionable insights. Dig into transactional trends, regulatory developments and market dynamics shaping life sciences dealmaking. You’ll hear from participants on all sides of deals.

If you’re in life sciences, the Symposium is the year’s can’t-miss event. Whether you are involved in investments, mergers and acquisitions, licensing, strategic partnerships or something adjacent, the industry’s future starts here.

You should be there, too.

REGISTER NOW

Women in Medtech, Powered by MassMEDIC, is proud to once again co-host the Women's Breakfast prior to the Symposium. Please use code LSDS25OFF to get 25% off registration.